KELLY FENIMORE-GONZALES: Open Payments
NPI 1720188295 · COLLEYVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 10 companies in 2025. Trend: 2023 $44 · 2024 $444 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Dynavax Technologies Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| PFIZER INC. | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Kerendia, Heplisav-B, MOUNJARO, AIRSUPRA, ELIQUIS, Korlym, TRELEGY ELLIPTA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
